Tumor interstitial fluid promotes malignant phenotypes of lung cancer independently of angiogenesis

Cancer Prevention Research
Hong LiGangjun Du

Abstract

Angiogenesis is necessary for cancer progression, but antiangiogenic therapy actually promotes tumor recurrence, progression, and metastasis. This study focused on the contribution of the tumor interstitial fluid (TIF) to lung cancer progression. TIF was isolated and quantified for 10 μg protein/mL. Malignant driver characteristics of TIF were examined by tumor-initiating cells (TIC), self-renewal, epithelial-mesenchymal transition (EMT), autophagy, and apoptosis in vitro. In vivo tumor model was used to investigate the mechanistic roles of TIF in lung cancer progression. In vitro, TIF exhibited distinct malignant driver characteristics, which led to increased numbers of TICs, increased self-renewal and EMT, as well as to decreased autophagy and apoptosis under cell starvation conditions. In vivo, the contribution of TIF was similar, as judged by increased TICs indicated by the cancer stem cell marker Nanog, the proliferation marker proliferating cell nuclear antigen, and the EMT marker N-cadherin; TIF also increased the formation of pulmonary tumors. Interestingly, the blockers of inflammation, Na-K-ATPase, and aldosterone receptor decreased TIF-induced tumor progression but increased angiogenesis. Further, we found that the w...Continue Reading

References

Aug 2, 2005·The Journal of Pharmacology and Experimental Therapeutics·Pierre-Luc TremblayFrançois A Auger
Oct 22, 2009·British Journal of Cancer·K LundgrenG Landberg
Apr 13, 2010·Angiogenesis·Jacobus F A JansenAmita Shukla-Dave
Jun 24, 2010·Cancer Research·Dalit BarkanJeffrey E Green
Nov 20, 2010·The American Journal of Pathology·Gemma LlaveriasPhilippe G Frank
Feb 9, 2011·Physical Biology·Adrian C Shieh, Melody A Swartz
Feb 25, 2011·Genome Medicine·Bo Wang, Samson T Jacob
Jun 2, 2011·Nature Reviews. Clinical Oncology·Katrien De BockPeter Carmeliet
Jun 15, 2012·Thrombosis Research·Francesca Elice, Francesco Rodeghiero
Aug 7, 2013·World Journal of Surgical Oncology·Shaomin LiShaoli Cheng
Feb 5, 2014·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Marietta TanPatrick K Ha
Jun 30, 2014·Advances in Cancer Research·Daohong ZhouDouglas R Spitz
Jul 6, 2014·Oncotarget·Elisabet CuyàsJavier A Menendez
Aug 30, 2014·Cancer Management and Research·Jennifer M Munson, Adrian C Shieh
Feb 6, 2015·OncoTargets and Therapy·Francesco SpagnoloPaola Queirolo
Apr 18, 2015·Journal of Translational Medicine·Jian WangHongzhi Sun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Zhonghua bing li xue za zhi Chinese journal of pathology
Dan-dan Zou, Xian-bin Tang
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine
Wen LuoXiaohui Guo
© 2021 Meta ULC. All rights reserved